Why are antidepressants preferred as first-line treatment for anxiety disorders?

Why Antidepressants Are Preferred for Anxiety Disorders

Antidepressants, particularly SSRIs and SNRIs, are preferred as first-line treatment for anxiety disorders because they effectively reduce anxiety symptoms with a favorable safety profile, avoid the dependency risks associated with benzodiazepines, and address the frequent comorbidity with depression. 1, 2

Efficacy Evidence

Antidepressants demonstrate robust efficacy across multiple anxiety disorder subtypes:

• For generalized anxiety disorder (GAD), antidepressants show clear superiority over placebo with a number needed to treat (NNTB) of 7, meaning only 7 patients need treatment for one additional patient to achieve at least 50% symptom reduction 3

• SSRIs and SNRIs are recommended as first-line pharmacotherapy by major international guidelines including NICE (UK), S3 (Germany), and Canadian CPG, with specific agents like escitalopram, sertraline, paroxetine, and venlafaxine consistently endorsed 1

• For social anxiety disorder, both SSRIs and SNRIs receive weak recommendations based on systematic reviews of 26 SSRI studies and 5 SNRI studies, though the evidence certainty is low 1

Safety and Tolerability Profile

The preference for antidepressants is heavily influenced by their safety advantages:

• Overall acceptability is equivalent to placebo, with no significant difference in total dropout rates (RR 1.03,95% CI 0.93-1.14) 3

• Dropout due to lack of efficacy is significantly lower with antidepressants compared to placebo (RR 0.41, NNTB of 27), demonstrating sustained patient engagement 3

• Dropout due to adverse effects is higher than placebo (RR 2.18, NNTH of 17), but this is offset by the absence of dependency risk that plagues benzodiazepines 3

• Benzodiazepines, while effective for panic disorder and GAD, carry substantial dependency risks and should be reserved for treatment-resistant cases in patients without substance abuse history 2

Addressing Comorbidity

A critical advantage of antidepressants is their dual utility:

• Anxiety and depression frequently co-occur, and the presence of comorbid conditions adversely affects clinical outcomes 4

• SSRIs are first-line treatment for patients with comorbid anxiety and depression, providing a single agent that addresses both conditions rather than requiring polypharmacy 4

• Approximately one-third of patients with social anxiety disorder have comorbid psychiatric disorders including other anxiety disorders, depression, and mood disorders 1

Comparative Effectiveness Among Antidepressants

When selecting specific agents within the antidepressant class:

• Duloxetine and escitalopram show superior efficacy in GAD, with escitalopram demonstrating the largest weighted mean difference on the Hamilton Anxiety Scale (−3.2 points) 5

• Vortioxetine shows better acceptability and tolerability but inferior efficacy compared to other antidepressants 5

• Fluoxetine and vortioxetine did not demonstrate significant superiority over placebo in some analyses, suggesting not all antidepressants are equally effective 5

Limitations of Alternative Treatments

Other medication classes have significant drawbacks:

• Tricyclic antidepressants (TCAs) are equally effective for some anxiety disorders but are less well-tolerated than SSRIs/SNRIs, relegating them to second- or third-line status 6, 2

• Beta-blockers (atenolol, propranolol) are specifically deprecated by Canadian guidelines based on negative evidence 1

• Anticonvulsants and atypical antipsychotics may have adjunctive roles in treatment-resistant cases but lack the evidence base for first-line use 6

Treatment Duration and Availability

Practical considerations support antidepressant use:

• Medication availability is universal across psychiatric facilities, and treatment is cost-effective with demonstrated efficacy 1

• Long-term safety data beyond two years remain limited, though there is increased risk of relapse when antidepressants are discontinued compared to continued use 7

• Treatment monitoring should be performed by physicians with expertise in anxiety disorder diagnosis and treatment 1

Common Pitfalls

Important caveats when using antidepressants for anxiety:

• Anxiety induction on initiation is a notable problem with SSRIs, requiring patient counseling about this transient effect 8

• Delayed onset of therapeutic effect means patients should be counseled about the 2-4 week lag before significant improvement 8

• Sexual dysfunction and sleep disturbance are common side effects that may require management strategies or medication switching 8

• Up to 30% of patients do not respond or respond inadequately to standard antidepressant treatment, necessitating alternative strategies 9